Clinical trial
High-Dose Ambroxol in GBA1-Related Parkinson
NCT06193421
Study timeline
Study start (actual)2023-10-24Date precision: day
Registry last updated2024-02-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Parkinson Diseaseunresolved
GBA Gene Mutationunresolved
Interventions
Ambroxol HydrochlorideDRUG · verified · RxNorm: ambroxol hydrochloride
Sponsors & collaborators
Agyany Pharma LTDlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06193421 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.